Viscosupplementation for Knee Osteoarthritis in St. Louis

A healthy knee runs on synovial fluid (the joint’s own oil), and that fluid is rich in hyaluronic acid. It lets the joint surfaces glide and soaks up load. In osteoarthritis the fluid thins out, like motor oil gone watery. Now the joint takes more stress with every step. Viscosupplementation puts a hyaluronic acid product right into the joint space to add back what the knee has lost. We often describe it to patients as a gel injection.

The knee is injected under ultrasound or fluoroscopic guidance so we can see the medicine land inside the joint, not in the tissue around it. Blind injection of the knee misses the joint more often than most people think. And a missed injection is a wasted one. Based on the product, treatment is either a single injection or a short series of weekly injections.

The usual candidate has mild to moderate knee osteoarthritis. Activity changes, physical therapy or a steroid injection have not helped enough. And the person is not ready for joint replacement.

We will be blunt about the evidence, because the guidance is not on our side. The American Academy of Orthopaedic Surgeons wrote a 2021 guideline on knee osteoarthritis. It recommends against routine use of hyaluronic acid shots into the joint. That is a moderate-strength call. Their reason: it gives little or no clinically important gain in pain or function compared with placebo. Other groups, including several in Europe, are more open to it. The split is real. Neither side is simply uninformed.

Our position: we tell you the AAOS recommends against routine use before we treat you, not after. Some patients do report real relief. It is still a fair option when the other choice is a joint replacement you are not ready for. But we offer it as an informed choice, with the guidance stated plainly. It is not a default.

Viscosupplementation works on the mechanics inside the joint. Genicular nerve blocks and genicular radiofrequency ablation instead cut off the nerves that carry pain away from the joint. The two are not rivals. They are different levers, and we often pull them one after the other. Which comes first depends on your imaging, your exam and how you have done with treatment so far.

Hyaluronic acid is a long-chain sugar molecule. The cells lining the joint make it. It lets the joint fluid change how it acts. During slow movement it works like oil. Under a sudden load it stiffens and works like a shock absorber. In osteoarthritis the knee makes less of it, and the chains get shorter. So the fluid loses both jobs and passes more stress to the cartilage.

Products differ in chain size and in whether the chains are cross-linked (tied together). That changes how long they last in the joint. The effect is likely not just mechanical, either. Injected hyaluronic acid seems to affect inflammation in the joint lining. It also seems to push the lining cells to make more of their own. That would explain why the benefit lasts longer than the gel stays in the knee. This proposed mechanism is plausible, and lab work backs it. But it is just the kind of indirect effect that has been hard to prove in clinical trials.